Stocks and Investing
Stocks and Investing
Tue, December 14, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, December 13, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Turrin Maintained (BLND) at Buy with Decreased Target to $15 on, Dec 13th, 2021
Michael Turrin of Wells Fargo, Maintained "Blend Labs, Inc." (BLND) at Buy with Decreased Target from $20 to $15 on, Dec 13th, 2021.
Michael has made no other calls on BLND in the last 4 months.
There are 2 other peers that have a rating on BLND. Out of the 2 peers that are also analyzing BLND, 0 agree with Michael's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Michael
- Arvind Ramnani of "Piper Sandler" Maintained at Buy with Decreased Target to $13 on, Friday, December 10th, 2021
- Josh Beck of "Keybanc" Maintained at Buy with Decreased Target to $16 on, Friday, November 12th, 2021
Contributing Sources